\-\ Texto\\:\\ \ \(0\)\
\-\ afebrile\\.\\ vss\\.\ \(0\)\
\-\ abdomen\\:\\ soft\\,\\ nontender\\ to\\ palpation\\.\ \(0\)\
\-\ 1\\)\\ cystectomy\\ and\\ close\\ interval\\ follow\\ up\\ for\\ recurrence\\ surveillance\\.\ \(0\)\
\-\ 1\\)\\ not\\ pictured\\:\\ noncontrast\\-enhanced\\ ct\\ abdomen\\/pelvis\\.\\ no\\ nephroureterolithiasis\\.\\ no\\ hydronephrosis\\.\\ soft\\ tissue\\ filling\\ defects\\ in\\ the\\ bladder\\ \\-\\ 1\\)\\ left\\ lateral\\ wall\\,\\ broad\\-based\\ mass\\,\\ 2\\)\\ trigone\\ filling\\ defect\\.\\ \ \(0\)\
\-\ 2\\)\\ status\\ post\\ iv\\ contrast\\:\ \(0\)\
\-\ a\\)\\ \\(2\\)\\ enhancing\\ bladder\\ masses\\.\ \(1\)\
\-\ b\\)\\ symmetric\\ enhancement\\ of\\ normal\\-sized\\ kidneys\\.\\ no\\ hydronephrosis\\.\\ no\\ concomitant\\ upper\\ tract\\ filling\\ defects\\.\ \(0\)\
\-\ transitional\\ cell\\ cancer\\ of\\ bladder\ \(0\)\
\-\ 1\\)\\ \\ urothelial\\ cell\\ tumor\\:\\ transitional\\ cell\\ carcinoma\ \(0\)\
\-\ 2\\)\\ \\ urothelial\\ cell\\ tumor\\:\\ squamous\\ cell\\ carcinoma\ \(0\)\
\-\ 3\\)\\ \\ urothelial\\ cell\\ tumor\\:\\ primary\\ adenocarcinoma\ \(0\)\
\-\ 4\\)\\ \\ metastatic\\ disease\ \(0\)\
\-\ 5\\)\\ \\ benign\\ bladder\\ tumor\\ types\\ ie\\ leiomyoma\ \(0\)\
\-\ 6\\)\\ \\ fungus\\ ball\ \(0\)\
\-\ 7\\)\\ \\ hematoma\ \(0\)\
\-\ 8\\)\\ \\ foreign\\ body\ \(0\)\
\-\ 9\\)\\ \\ enlarged\\ prostate\ \(0\)\
\-\ 10\\)\\ \\ ureterocoele\ \(0\)\
\-\ 11\\)\\ urethral\\ diverticulum\\ \\(\\"female\\ prostate\\"\\)\ \(0\)\
\-\ 12\\)\\ cystitis\\ glandularis\ \(0\)\
\-\ 13\\)\\ schistosomiasis\ \(0\)\
\-\ 60\\ year\\ old\\ male\\ presents\\ with\\ right\\ flank\\ pain\\ and\\ frank\\ hematuria\\.\ \(1\)\
\-\ the\\ patient\\ has\\ a\\ typical\\ profile\\ in\\ terms\\ of\\ age\\ and\\ gender\\.\\ also\\,\\ his\\ presentation\\ is\\ consistent\\ though\\ nonspecific\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ urothelial\\:\\ 0\\.3392642535700378\ \(0\)\
\-\ cell\\:\\ 0\\.2984921208662534\ \(0\)\
\-\ bladder\\:\\ 0\\.2699436922528079\ \(0\)\
\-\ filling\\:\\ 0\\.20204197831403514\ \(0\)\
\-\ transitional\\:\\ 0\\.1875845826654155\ \(0\)\
\-\ tumor\\:\\ 0\\.18195352331794704\ \(0\)\
\-\ prostate\\:\\ 0\\.16846976621894483\ \(0\)\
\-\ hydronephrosis\\:\\ 0\\.16141628157344634\ \(0\)\
\-\ defects\\:\\ 0\\.14995005827938426\ \(0\)\
\-\ nephroureterolithiasis\\:\\ 0\\.139077924597384\ \(0\)\
\-\ ureterocoele\\:\\ 0\\.13289638178568516\ \(0\)\
\-\ glandularis\\:\\ 0\\.13289638178568516\ \(0\)\
\-\ pictured\\:\\ 0\\.1199788510450447\ \(0\)\
\-\ cystectomy\\:\\ 0\\.11794309012824084\ \(0\)\
\-\ no\\:\\ 0\\.11312170577250968\ \(0\)\
\-\ trigone\\:\\ 0\\.11054125137897819\ \(0\)\
\-\ schistosomiasis\\:\\ 0\\.11054125137897819\ \(0\)\
\-\ abdomen\\:\\ 0\\.106127778708729\ \(0\)\
\-\ fungus\\:\\ 0\\.10558000450484314\ \(0\)\
\-\ carcinoma\\:\\ 0\\.1040385287393278\ \(0\)\
\-\ cystitis\\:\\ 0\\.10252066728877435\ \(0\)\
\-\ gender\\:\\ 0\\.10184297525586636\ \(0\)\
\-\ vss\\:\\ 0\\.0999738341444066\ \(0\)\
\-\ ie\\:\\ 0\\.09939846169314431\ \(0\)\
\-\ profile\\:\\ 0\\.09939846169314431\ \(0\)\
\-\ concomitant\\:\\ 0\\.09884401657590151\ \(0\)\
\-\ terms\\:\\ 0\\.09884401657590151\ \(0\)\
\-\ urethral\\:\\ 0\\.0963391244770755\ \(0\)\
\-\ surveillance\\:\\ 0\\.09501258727027156\ \(0\)\
\-\ soft\\:\\ 0\\.09259793393827966\ \(0\)\
\-\ ball\\:\\ 0\\.09230373814376827\ \(0\)\
\-\ leiomyoma\\:\\ 0\\.09031236025813379\ \(0\)\
\-\ frank\\:\\ 0\\.0891160165021493\ \(0\)\
\-\ nontender\\:\\ 0\\.08191463359030711\ \(0\)\
\-\ nonspecific\\:\\ 0\\.08173632090919668\ \(0\)\
\-\ types\\:\\ 0\\.08087476059206727\ \(0\)\
\-\ foreign\\:\\ 0\\.07883899967526341\ \(0\)\
\-\ close\\:\\ 0\\.07869310803142555\ \(0\)\
\-\ interval\\:\\ 0\\.07869310803142555\ \(0\)\
\-\ squamous\\:\\ 0\\.07826362722400113\ \(0\)\
\-\ diverticulum\\:\\ 0\\.07704333128643732\ \(0\)\
\-\ hematuria\\:\\ 0\\.07691358105272492\ \(0\)\
\-\ flank\\:\\ 0\\.07628089439697046\ \(0\)\
\-\ though\\:\\ 0\\.07555477809749785\ \(0\)\
\-\ afebrile\\:\\ 0\\.0750892286282701\ \(0\)\
\-\ kidneys\\:\\ 0\\.0748616787257956\ \(0\)\
\-\ symmetric\\:\\ 0\\.07452659797502433\ \(0\)\
\-\ tract\\:\\ 0\\.07285417650186343\ \(0\)\
\-\ recurrence\\:\\ 0\\.07180234150972681\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.07108052336659483\ \(0\)\
\-\ typical\\:\\ 0\\.06720997778436996\ \(0\)\
\-\ 13\\:\\ 0\\.06559003065440758\ \(0\)\
\-\ 11\\:\\ 0\\.06510600395538288\ \(0\)\
\-\ 60\\:\\ 0\\.06504656699729479\ \(0\)\
\-\ defect\\:\\ 0\\.06379436226558148\ \(0\)\
\-\ iv\\:\\ 0\\.06213898208014081\ \(0\)\
\-\ hematoma\\:\\ 0\\.060869743691429175\ \(0\)\
\-\ status\\:\\ 0\\.060690382088068554\ \(0\)\
\-\ presentation\\:\\ 0\\.05986609699840643\ \(0\)\
\-\ benign\\:\\ 0\\.059739926122924086\ \(0\)\
\-\ 12\\:\\ 0\\.0594495257152384\ \(0\)\
\-\ enlarged\\:\\ 0\\.05928603288363909\ \(0\)\
\-\ masses\\:\\ 0\\.05920493928584583\ \(0\)\
\-\ palpation\\:\\ 0\\.058649049981566545\ \(0\)\
\-\ cancer\\:\\ 0\\.0579256542413206\ \(0\)\
\-\ body\\:\\ 0\\.057235034024098075\ \(0\)\
\-\ age\\:\\ 0\\.054598256309465076\ \(0\)\
\-\ enhancing\\:\\ 0\\.054479149762723195\ \(0\)\
\-\ and\\:\\ 0\\.053911516328021825\ \(0\)\
\-\ primary\\:\\ 0\\.05347484578473546\ \(0\)\
\-\ wall\\:\\ 0\\.05290255916699029\ \(0\)\
\-\ his\\:\\ 0\\.05274291833198519\ \(0\)\
\-\ of\\:\\ 0\\.05105671525158009\ \(0\)\
\-\ 10\\:\\ 0\\.050853430813609456\ \(0\)\
\-\ enhancement\\:\\ 0\\.05005624457003062\ \(0\)\
\-\ metastatic\\:\\ 0\\.04769662338642296\ \(0\)\
\-\ post\\:\\ 0\\.04732109798609442\ \(0\)\
\-\ consistent\\:\\ 0\\.04715508298330674\ \(0\)\
\-\ follow\\:\\ 0\\.04688234654266565\ \(0\)\
\-\ upper\\:\\ 0\\.04647340320209861\ \(0\)\
\-\ tissue\\:\\ 0\\.045620520858801764\ \(0\)\
\-\ in\\:\\ 0\\.04326874818258161\ \(0\)\
\-\ lateral\\:\\ 0\\.04315942702208083\ \(0\)\
\-\ up\\:\\ 0\\.04301891394963034\ \(0\)\
\-\ contrast\\:\\ 0\\.04225511255998899\ \(0\)\
\-\ female\\:\\ 0\\.041965214171186045\ \(0\)\
\-\ presents\\:\\ 0\\.04183524270677617\ \(0\)\
\-\ also\\:\\ 0\\.040906419324813356\ \(0\)\
\-\ has\\:\\ 0\\.039723637088360776\ \(0\)\
\-\ male\\:\\ 0\\.0387207083160073\ \(0\)\
\-\ disease\\:\\ 0\\.03650533128882368\ \(0\)\
\-\ the\\:\\ 0\\.034705825715639356\ \(0\)\
\-\ not\\:\\ 0\\.0343321964810634\ \(0\)\
\-\ mass\\:\\ 0\\.03321877594170361\ \(0\)\
\-\ ct\\:\\ 0\\.0331088579425676\ \(0\)\
\-\ pain\\:\\ 0\\.03111971537802847\ \(0\)\
\-\ left\\:\\ 0\\.02966607570153679\ \(0\)\
\-\ right\\:\\ 0\\.02883290151883086\ \(0\)\
\-\ patient\\:\\ 0\\.028285746827211886\ \(0\)\
\-\ year\\:\\ 0\\.026801277983328615\ \(0\)\
\-\ for\\:\\ 0\\.0263587950222222\ \(0\)\
\-\ old\\:\\ 0\\.02573850435660499\ \(0\)\
\-\ is\\:\\ 0\\.023816291260595805\ \(0\)\
\-\ to\\:\\ 0\\.02174138514394133\ \(0\)\
\-\ with\\:\\ 0\\.017029073875592257\ \(0\)\
